| AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations K Yen, J Travins, F Wang, MD David, E Artin, K Straley, A Padyana, ... Cancer discovery 7 (5), 478-493, 2017 | 412 | 2017 |
| Review of therapeutic drug monitoring of anticancer drugs part two–targeted therapies N Widmer, C Bardin, E Chatelut, A Paci, J Beijnen, D Levêque, G Veal, ... European journal of cancer 50 (12), 2020-2036, 2014 | 338 | 2014 |
| Review of therapeutic drug monitoring of anticancer drugs part 1–cytotoxics A Paci, G Veal, C Bardin, D Levêque, N Widmer, J Beijnen, A Astier, ... European journal of cancer 50 (12), 2010-2019, 2014 | 281 | 2014 |
| Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer C Coutzac, JM Jouniaux, A Paci, J Schmidt, D Mallardo, A Seck, ... Nature communications 11 (1), 2168, 2020 | 276 | 2020 |
| Crizotinib-induced immunogenic cell death in non-small cell lung cancer P Liu, L Zhao, J Pol, S Levesque, A Petrazzuolo, C Pfirschke, C Engblom, ... Nature communications 10 (1), 1486, 2019 | 233 | 2019 |
| Vemurafenib in pediatric patients with BRAFV600E mutated high‐grade gliomas F Bautista, A Paci, V Minard‐Colin, C Dufour, J Grill, L Lacroix, P Varlet, ... Pediatric blood & cancer 61 (6), 1101-1103, 2014 | 153 | 2014 |
| Personalizing busulfan-based conditioning: considerations from the american society for blood and marrow transplantation practice guidelines committee J Palmer, JS McCune, MA Perales, D Marks, J Bubalo, M Mohty, ... Biology of Blood and Marrow Transplantation 22 (11), 1915-1925, 2016 | 146 | 2016 |
| Therapeutic drug monitoring in cancer–are we missing a trick? C Bardin, G Veal, A Paci, E Chatelut, A Astier, D Levêque, N Widmer, ... European journal of cancer 50 (12), 2005-2009, 2014 | 134 | 2014 |
| Human pharmacokinetic study of heated intraperitoneal oxaliplatin in increasingly hypotonic solutions after complete resection of peritoneal carcinomatosis D Elias, A El Otmany, M Bonnay, A Paci, M Ducreux, S Antoun, P Lasser, ... Oncology 63 (4), 346-352, 2002 | 129 | 2002 |
| Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo … MH Massicotte, I Borget, S Broutin, VE Baracos, S Leboulleux, E Baudin, ... The Journal of Clinical Endocrinology & Metabolism 98 (6), 2401-2408, 2013 | 123 | 2013 |
| The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development F Lemonnier, RA Cairns, S Inoue, WY Li, A Dupuy, S Broutin, N Martin, ... Proceedings of the National Academy of Sciences 113 (52), 15084-15089, 2016 | 111 | 2016 |
| Squalenoylation favorably modifies the in vivo pharmacokinetics and biodistribution of gemcitabine in mice LH Reddy, H Khoury, A Paci, A Deroussent, H Ferreira, C Dubernet, ... Drug Metabolism and Disposition 36 (8), 1570-1577, 2008 | 110 | 2008 |
| Mitotane alters mitochondrial respiratory chain activity by inducing cytochrome c oxidase defect in human adrenocortical cells S Leboulleux, R Chadarevian, S Trabado, L Amazit Endocr. Relat. Cancer 20, 371-381, 2013 | 107 | 2013 |
| Oxazaphosphorines: new therapeutic strategies for an old class of drugs B Giraud, G Hebert, A Deroussent, GJ Veal, G Vassal, A Paci Expert opinion on drug metabolism & toxicology 6 (8), 919-938, 2010 | 106 | 2010 |
| Pharmacokinetic behavior and appraisal of intravenous busulfan dosing in infants and older children: the results of a population pharmacokinetic study from a large pediatric … A Paci, G Vassal, D Moshous, JH Dalle, N Bleyzac, B Neven, ... Therapeutic drug monitoring 34 (2), 198-208, 2012 | 92 | 2012 |
| Serum detection of nonadherence to adjuvant tamoxifen and breast cancer recurrence risk B Pistilli, A Paci, AR Ferreira, A Di Meglio, V Poinsignon, A Bardet, ... Journal of Clinical Oncology 38 (24), 2762, 2020 | 91 | 2020 |
| Phase II study of vinorelbine and continuous low doses cyclophosphamide in children and young adults with a relapsed or refractory malignant solid tumour: good tolerance … V Minard-Colin, JL Ichante, L Nguyen, A Paci, D Orbach, C Bergeron, ... European Journal of Cancer 48 (15), 2409-2416, 2012 | 84 | 2012 |
| Dihydropyrimidine dehydrogenase (DPD) deficiency screening and securing of fluoropyrimidine-based chemotherapies: update and recommendations of the French GPCO-Unicancer and … MA Loriot, J Ciccolini, F Thomas, C Barin-Le-Guellec, B Royer, G Milano, ... Bulletin du cancer 105 (4), 397-407, 2018 | 83 | 2018 |
| Liquid chromatography–tandem mass spectrometry assay of reduced and oxidized glutathione and main precursors in mice liver J Bouligand, A Deroussent, A Paci, J Morizet, G Vassal Journal of Chromatography B 832 (1), 67-74, 2006 | 80 | 2006 |
| Pharmacology of dimethanesulfonate alkylating agents: busulfan and treosulfan A Galaup, A Paci Expert opinion on drug metabolism & toxicology 9 (3), 333-347, 2013 | 75 | 2013 |
Couvreur PUniversité Paris-SaclayVerified email at universite-paris-saclay.fr
